Remdesivir resistance in transplant recipients with persistent COVID-19

The medical community currently lacks robust data regarding the incidence, prevalence, and clinical significance of mutations associated with resistance to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) therapeutics. This report describes two renal transplant recipients who, after remd...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogan, John I, Duerr, Ralf, Dimartino, Dacia, Marier, Christian, Hochman, Sarah, Mehta, Sapna, Wang, Guiqing, Heguy, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258299/
https://www.ncbi.nlm.nih.gov/pubmed/35794888
http://dx.doi.org/10.21203/rs.3.rs-1800050/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258299/
https://www.ncbi.nlm.nih.gov/pubmed/35794888
http://dx.doi.org/10.21203/rs.3.rs-1800050/v1

Ejemplares similares